Duns Number:045361136
Device Description: For use as controls in the Quantitative Determination of Hemoglobin (HbA1c) in human blood For use as controls in the Quantitative Determination of Hemoglobin (HbA1c) in human blood.
Catalog Number
0355-201
Brand Name
Direct Glycohemoglobin (HbA1c) Control Set
Version/Model Number
0355-201
Device Commercial Distribution Status
In Commercial Distribution
Commercial Distribution End Date
-
Issuing Agency
In GS1
MRI safety Status
Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)
-
Device labeled as "Not made with natural rubber latex"
-
For Single-Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
-
Kit
-
Combination Product
-
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)
-
FDA Premarket Submission
-
Product Code
LCP
Product Code Name
Assay, Glycosylated Hemoglobin
Public Device Record Key
de3690c0-cf1e-49f4-a6a6-07c942e70b51
Public Version Date
March 29, 2018
Public Version Number
2
DI Record Publish Date
September 23, 2016
Package DI Number
None
Quantity per Package
-
Contains DI Package
-
Package Discontinue Date
-
Package Status
-
Package Type
-
Device Class | Device Class Description | No of Devices |
---|---|---|
1 | A medical device with low to moderate risk that requires general controls | 69 |
2 | A medical device with a moderate to high risk that requires special controls. | 86 |